A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.
about
Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.
P2860
A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A multifactorial histopatholog ...... fter neoadjuvant chemotherapy.
@en
A multifactorial histopatholog ...... fter neoadjuvant chemotherapy.
@nl
type
label
A multifactorial histopatholog ...... fter neoadjuvant chemotherapy.
@en
A multifactorial histopatholog ...... fter neoadjuvant chemotherapy.
@nl
prefLabel
A multifactorial histopatholog ...... fter neoadjuvant chemotherapy.
@en
A multifactorial histopatholog ...... fter neoadjuvant chemotherapy.
@nl
P2093
P2860
P1476
A multifactorial histopatholog ...... fter neoadjuvant chemotherapy.
@en
P2093
Florian Lordick
Heinz Höfler
Inti Zlobec
Julia Slotta-Huspenina
Karen Becker
Leila Sisic
Marcus Feith
Ralf Gertler
Wilko Weichert
P2860
P2888
P304
P356
10.1245/S10434-013-3410-Y
P577
2013-11-27T00:00:00Z
P5875
P6179
1011950414